Overcoming the Barriers to Effective Transcranial Temporal Interference Stimulation in Humans
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Northeastern University
- Study ID
- NCT07593859
- Status
- Recruiting
Conditions
- Healthy Adult Participants
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 65 Years
- Healthy Volunteers
- Accepted
Interventions
- transcranial Temporal Interference Stimulation — DEVICEWe will apply temporal interference stimulation (tTIS) for 20 minutes over the motor cortex concurrent with single-pulse transcranial magnetic stimulation (TMS) (also over the motor cortex). Motor evoked potentials will be recorded using electromyography (EMG).
Study Details
Transcranial temporal interference stimulation (TIS) is an emerging novel tool for non-invasive transcranial brain stimulation that holds the potential for focal and steerable neuromodulation, and the possibility to stimulate focally at depth. TIS involves combining two high frequency waveforms to create a waveform with a "beat" frequency that is physiological relevant for neuromodulation. Successful applications to deep brain targets as well as steerability of the stimulation focus have been demonstrated in mice. Numerous recent investigations in humans have shown great clinical potential for this technology, however several questions about the basic mechanism of TIS action remain. The investigators will apply TIS to the motor cortex of humans and use established transcranial magnetic stimulation techniques to assess cortical excitability in relation to the phase of the TIS waveform. Using TMS, the investigators will i) validate that effects of TIS are due to the "beat" frequency and not the high frequency carrier signal, ii) evaluate the effect of the TIS carrier frequency, and iii) evaluate that whether changes in corticospinal excitability outlast the period of stimulation. Knowledge gained from this experiment will provide a basis for the future use of TIS for clinical applications, including informing parameter optimization.
Key Dates
- Start date
- Feb 1, 2026
- Status verified
- May 2026
- Primary completion
- Oct 1, 2029
- Completion
- Oct 1, 2029
Study Design
- Enrollment
- 30 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: 990-1010 Hz fb990-1010 Hz fb
- Experimental: 1990-2010 Hz fb1990-2010 Hz fb
- Experimental: 1000-1000 Hz fb1000-1000 Hz fb
- Experimental: 2000-2000 Hz fb2000-2000 Hz fb
- Experimental: 20 Hz20 Hz
- Sham Comparator: shamsham
Primary Outcome Measure
Online phase-dependent modulation of corticospinal excitability using the relevance value (R.V.) [ Time Frame: Periprocedural ]
Central Contacts
- Joanne Hall, M.Sc.17027828483
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Northeastern University | Boston | Massachusetts | 02115-5724 | Mathew Yarossi, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Boston, MA
Related Studies
- A Usability Study of a Multi-channel ECG Monitoring DeviceNot Yet Recruiting · Wearlinq · New London, North Carolina
- Acute Effects of Alpha-glycerylphosphorylcholine (A-GPC) on Lower Body Muscular Performance.Not Yet Recruiting · Northern Illinois University · DeKalb, Illinois
- Kimchi and Gut HealthRecruiting · University of California, Davis · Davis, California
- A Study to Evaluate EDG-7500 in Caucasian and Japanese AdultsPHASE1 · Not Yet Recruiting · Edgewise Therapeutics, Inc. · Glendale, California